to save a life with early detection of cervical cancer

to save a life with early detection of
cervical cancer
• Pap cytology does not uncover all disease1,2
• Normal cytology does not always mean cancer free1,2
• 99 % of cervical cancer is attributable to hrHPV
genotypes3,4
1 sample, 1 test, 3 results for
confi dent risk stratifi cation:
The cobas® HPV Test detects 14 high-risk genotypes with
the ability to provide specifi c genotype results for HPV16
and HPV18.
References: 1. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97:675-
683. 2. Andrae B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100:622-629. 3. Naucler P, Ryd W, Törnberg
S, et al. Effi cacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening. J Natl Cancer Inst. 2009;101:88-99. 4. Wallboomers JMM, Jacobs MV, Manos
MM, et al. Human papilloma virus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
For more information kindly refer to the following websites
www.hpv16and18.com; www.sasog.co.za
Roche Diagnostics (Pty) Ltd, PO BOX 1927, Randburg, 2125. Tel: [phone]. www.roche.co.za A0005.
• 99 % of cervical cancer is attributable to hrHPV
• Normal cytology does not always mean cancer free
• Pap cytology does not uncover all disease
Call Centre: 0861 cobas HPV (262274)
HPV advert.indd 1 2013/03/05 9:08 AM